Humana Inc. is a healthcare company operating through two reportable segments: Insurance and CenterWell. The Insurance segment provides medical and specialty insurance products, primarily serving Medicare beneficiaries through Individual and Group Medicare Advantage plans, stand-alone prescription drug plans, and Medicare Supplement plans. It also offers state-based contracts, military services, and operates a Pharmacy Benefit Manager (PBM) business. The CenterWell segment delivers adjacent health care services, including primary care, pharmacy solutions, and home solutions, supporting an integrated care delivery model focused on population health and value-based arrangements. Humana serves Medicare and Medicaid participants, families, individuals, and military service personnel across all 50 U.S. states, with significant contracts with the federal government and state agencies. The company was organized in 1964.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Healthcare Plans Homepage humana.com
Sector Healthcare IR page —
Tags
medicare advantage, medicare supplement, pharmacy benefit manager, primary care, population health, value-based care, specialty benefits, military health, medicaid, chronic care management, CenterWell, Humana
Press page —

Metrics

Valuation  
Market cap $ 52.914B
Market cap (USD) $ 52.914B
P/E 42.77
PEG —
P/BV 2.81
P/S 7.47
P/OCF 14.18
P/FCF 16.86
Dividend yield 0.20%
Turnover / mcap —
Returns  
ROE 7.0%
ROI 4.0%
ROIC 7.4%
Profit margin 20.4%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -24.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 66.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 15
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 5.833B 4.431B 4.033B 4.776B 3.055B 1.815B 1.439B 1.457B 53.767B 54.379B 54.289B 48.5B 41.313B 39.126B 36.832B 33.868B 30.96B 28.946B 25.29B 21.417B 14.418B 13.104B 12.226B 11.261B 10.195B 10.514B
Net profit 1.188B 1.207B 2.489B 2.806B 2.933B 3.367B 2.707B 1.683B 2.448B 614M 1.276B 1.147B 1.231B 1.222B 1.419B 1.099B 1.04B 647.154M 833.684M 487.423M 308.483M 280.012M 228.934M 142.755M 117.171M 90M
Free cash flow 375M 2.391B 2.977B 3.467B 946M 4.675B 4.548B 1.561B 3.525B 1.409B 345M 1.09B 1.275B 1.513B 1.733B 2.019B 1.236B 720.738M 985.018M 1.494B 459.781M 233.713M 311.872M 209.272M 33.987M -95M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 256.13 253.71 457.81 512.19 463.86 410.27 366.52 286.48 248.07 204.03 178.51 143.63 103.22 68.63 87.61 54.72 43.88 37.28 77.26 52 — — — — — —
Price performance 12m 0.01 -0.45 -0.11 0.1 0.13 0.12 0.28 0.15 0.22 0.14 0.24 0.39 0.5 -0.22 0.6 0.25 0.18 -0.52 0.49 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 1.28B 854M 1.02B 1.06B 1.14B 1.81B 1.67B 2.04B 2.7B 3.27B
↳ YoY growth +10.2% -33.3% +18.9% +4.0% +7.8% +59.4% -7.7% +21.6% +32.9% +20.9%
↳ 5y CAGR +4.4% +3.1% +1.3% -2.0% -0.4% +7.2% +14.4% +14.9% +20.7% +23.5%
Borrowings, current (USD) 300M 150M 1.69B 699M 600M 1.95B 2.09B 1.44B 577M 0.00
Borrowings, non-current (USD) 3.79B 4.77B 4.38B 4.97B 6.06B 10.5B 9.03B 10.2B 11.1B 12.4B
Lease liabilities (USD) — — — 448M 484M 731M 608M 593M 522M 544M
Cash and deposits (USD) 3.88B 4.04B 2.34B 4.05B 4.67B 3.39B 5.06B 4.69B 2.22B 4.2B
Intangible assets (USD) 280M 226M 245M 177M 329M 2.64B 1.77B 1.69B 1.44B 1.13B
Right-of-use assets (USD) — — — 410M 437M 678M 515M 510M 445M 485M
Net debt (borrowings + leases - cash) (USD) 215M 878M 3.73B 2.06B 2.47B 9.83B 6.67B 7.56B 10B 8.71B
Cash flow detail
Operating cash flow (USD) 1.94B 4.05B 2.17B 5.28B 5.64B 2.26B 4.59B 3.98B 2.97B 921M
Purchases of property, plant and equipment (USD) -527M -526M -612M -736M -964M -1.32B -1.12B -1B -575M -546M
Change in receivables (cash effect) (USD) -158M 406M -200M -32M -85M -280M -54M -337M -669M -570M
Dividends paid (cash effect) (USD) -177M -220M -265M -291M -323M -90M -98M -431M -431M -430M
Share buybacks (cash effect) (USD) -104M -3.37B -1.09B -1.07B -1.82B -79M -2.1B -1.57B -817M -151M
Interest paid (cash effect) (USD) -185M -216M -195M -212M -258M -285M -354M -394M -584M -628M
Income taxes paid (cash effect) (USD) -916M -1.5B -631M -518M -1.13B -227M -758M -997M -570M —
Share-based compensation (USD) 115M 157M 137M 163M 181M 180M 216M 175M 207M 241M
Operating cash flow before change in receivables (USD) 2.09B 3.65B 2.37B 5.32B 5.72B 2.54B 4.64B 4.32B 3.64B 1.49B
Free cash flow (OCF - PPE - intangibles) (USD) 1.41B 3.53B 1.56B 4.55B 4.68B 946M 3.47B 2.98B 2.39B 375M
Income detail
Total comprehensive income (USD) 490M 2.53B 1.51B 3.02B 3.6B 2.58B 1.46B 2.79B 1.14B 1.62B
Comprehensive income to owners (USD) 490M 2.53B 1.51B 3.02B 3.6B 2.58B 1.46B 2.79B 1.14B 1.62B
Provision for credit losses (USD) 39M 20M 36M — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 3.2% 1.9% 3.9% — — — — — — —
Reported Feb 17, 2017 Feb 16, 2018 Feb 21, 2019 Feb 20, 2020 Feb 18, 2021 Feb 17, 2022 Feb 16, 2023 Feb 15, 2024 Feb 20, 2025 Feb 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

101 East Main Street Bull 1 Bear 0 Financing

Louisville, KY 40202

Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Louisville, KY - November 16, 2026 - Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 9, 2026 (the “Offer to Purchase”).

101 East Main Street Bull 2 Bear 0 Financing

Louisville, KY 40202

Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Louisville, KY - November 9, 2026 – Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced that it has commenced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 9, 2026 (the “Offer to Purchase”).

The Notes offered to be purchased in the Offers, in the order of acceptance priority, are the 2.150% Senior Notes due 2032; 3.125% Senior Notes due 2029; 3.700% Senior Notes due 2029; 4.875% Senior Notes due 2030; 1.350% Senior Notes due 2027; 3.950% Senior Notes due 2027; 5.375% Senior Notes due 2031; and 5.750% Senior Notes due 2028 (collectively, the “Notes”) for the consideration described below, up to an aggregate purchase price, excluding the Accrued Coupon Payment (as defined below), of $1,500,000,000 (the “Tender Cap”) subject to proration and the application of the Acceptance Priority Levels set forth in the table below and as further set forth in the Offer to Purchase and the terms and conditions, incl

Regulation FD Disclosure

Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended September 30, 2026, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company’s website at www.humana.com. A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. Additionally, a copy of management's prepared remarks on the Company's financial results for the quarter ended September 30, 2026 and expectations for future earnings, is attached hereto as Exhibit 99.3, and incorporated herein by reference.

Prompts

Humana Inc. (ticker HUM), listed in United States.

Company History

Date Change Detail
Nov 8, 2012 Acquired Acquired Metropolitan Health Networks Inc (CIK 1009379). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Humana Inc.

ETF Weight in ETF Shares Market value As of
PINK 5.09% 38,405 $ 17.026M Nov 17, 2026
EAGL 4.04% 433,119 $ 172.044M Jun 30, 2026
FMTM 3.07% 21,303 $ 7.751M Jul 31, 2026
TGLB 2.57% 1,854 $ 674.596K Jul 31, 2026
EPMV 2.20% 225 $ 101.25K Nov 13, 2026
QVAL 2.13% 34,976 $ 15.51M Nov 18, 2026
SAGP 2.04% 3,935 $ 1.563M Jun 30, 2026
CNAV 2.01% 3,146 $ 1.25M Jun 30, 2026
JDOC 1.98% 441 $ 195.513K Nov 17, 2026
CVAR 1.71% 2,014 $ 732.814K Jul 31, 2026
MKTN 1.39% 3,748 $ 1.489M Jun 30, 2026
TMED 1.24% 721 $ 286.396K Jun 30, 2026
HWSM 1.23% 85 $ 33.764K Jun 30, 2026
ITAN 1.03% 2,858 $ 1.267M Nov 17, 2026
CGMM 0.98% 76,760 $ 35.406M Nov 16, 2026
FMDE 0.96% 178,887 $ 71.057M Jun 30, 2026
MCDS 0.90% 159 $ 70.491K Nov 17, 2026
FLDZ 0.89% 91 $ 36.147K Jun 30, 2026
AVIE 0.83% 301 $ 138.836K Nov 16, 2026
LSEQ 0.80% 296 $ 133.2K Nov 13, 2026
MFSV 0.79% 12,383 $ 4.746M Aug 31, 2026
AVMC 0.65% 7,737 $ 3.569M Nov 16, 2026
GMOV 0.52% 1,452 $ 556.45K Aug 31, 2026
LVDS 0.51% 1,380 $ 611.809K Nov 17, 2026
BTAL short -0.50% -3,542 $ -1.407M Jun 30, 2026
GOP 0.42% 791 $ 364.849K Nov 17, 2026
HELO 0.42% 45,239 $ 20.056M Nov 17, 2026
BRCE 0.33% 320 $ 122.634K Aug 31, 2026
JEPI 0.33% 347,825 $ 154.205M Nov 17, 2026
DFLV 0.33% 56,948 $ 25.267M Nov 12, 2026
FFLC 0.32% 10,722 $ 3.901M Jul 31, 2026
AFLG 0.32% 6,468 $ 2.983M Nov 16, 2026
FEAC 0.31% 204 $ 81.033K Jun 30, 2026
AIVL 0.31% 3,251 $ 1.291M Jun 30, 2026
LGDX 0.30% 886 $ 408.668K Nov 17, 2026
JUSA 0.28% 5,426 $ 2.406M Nov 17, 2026
AVSU 0.27% 2,825 $ 1.303M Nov 16, 2026
JAVA 0.25% 42,732 $ 18.945M Nov 17, 2026
LCTU 0.24% 5,801 $ 2.676M Nov 16, 2026
CAPE 0.22% 1,322 $ 525.125K Jun 30, 2026
FLCV 0.22% 799 $ 306.201K Aug 31, 2026
GSPY 0.21% 3,098 $ 1.429M Nov 17, 2026
FLCC 0.21% 727 $ 278.608K Aug 31, 2026
DFSU 0.20% 10,691 $ 4.743M Nov 12, 2026
ACVF 0.19% 790 $ 287.449K Jul 31, 2026
DFUV 0.18% 63,068 $ 27.982M Nov 12, 2026
HBTA 0.17% 1,112 $ 426.152K Aug 31, 2026
VFMO 0.15% 7,661 $ 2.936M Aug 31, 2026
FYEE 0.14% 839 $ 305.279K Jul 31, 2026
VFMF 0.14% 3,553 $ 1.362M Aug 31, 2026
XMAG 0.13% 628 $ 278.631K Nov 13, 2026
AVLC 0.13% 4,521 $ 2.085M Nov 16, 2026
AAUS 0.13% 1,444 $ 640K Nov 18, 2026
MODL 0.10% 2,647 $ 1.051M Jun 30, 2026
INRO 0.10% 1,343 $ 619.459K Nov 16, 2026
DFAC 0.09% 183,616 $ 81.467M Nov 12, 2026
FELV 0.09% 7,102 $ 2.821M Jun 30, 2026
DFAU 0.08% 23,210 $ 10.298M Nov 12, 2026
DFUS 0.08% 37,957 $ 16.841M Nov 12, 2026
DCOR 0.08% 77,924 $ 34.573M Nov 12, 2026
DXUV 0.08% 10,666 $ 4.732M Nov 12, 2026
TACU 0.07% 29 $ 13.376K Nov 17, 2026
AVUS 0.07% 21,084 $ 9.725M Nov 16, 2026
NTSD 0.07% 62 $ 24.628K Jun 30, 2026
APUE 0.06% 4,102 $ 1.572M Aug 31, 2026
VOXP 0.06% 9 $ 3,274.74 Jul 31, 2026
HCMT 0.05% 835 $ 303.823K Jul 31, 2026
GDE 0.05% 670 $ 256.764K Aug 31, 2026
NTSX 0.05% 1,566 $ 622.047K Jun 30, 2026
MSLC 0.04% 4,617 $ 1.769M Aug 31, 2026
IALT short -0.04% -7,409 $ -3.417M Nov 16, 2026
CSHP 0.03% 245 $ 113.006K Nov 16, 2026
DYNF 0.03% 28,812 $ 13.29M Nov 16, 2026
VFVA 0.03% 708 $ 271.327K Aug 31, 2026
DFVX 0.01% 135 $ 59.897K Nov 12, 2026
EBI 0.00% 82 $ 31.425K Aug 31, 2026
FELC 0.00% 20 $ 7,944.40 Jun 30, 2026
CORO 0.00% 76 $ 34.935K Nov 16, 2026
GVLU 0.00% 24 $ 11.07K Nov 17, 2026